{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:46:06Z","timestamp":1794548766167,"version":"4.9.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16104-0","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T04:14:22Z","timestamp":1777263262000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The dual role of baseline absolute eosinophil count in non-small cell lung cancer immunotherapy: a biomarker for enhanced efficacy and elevated risk of immune checkpoint inhibitor-related pneumonitis"],"prefix":"10.1186","volume":"26","author":[{"given":"Mengying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuanying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"9","key":"16104_CR1","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","volume":"20","author":"A Leiter","year":"2023","unstructured":"Leiter A, Veluswamy RR, Wisnivesky JP. The global burden of lung cancer: current status and future trends. Nat Reviews Clin Oncol. 2023;20(9):624\u201339.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"3","key":"16104_CR2","first-page":"203","volume":"4","author":"H Zeng","year":"2024","unstructured":"Zeng H, Zheng R, Sun K, Zhou M, Wang S, Li L, et al. Cancer survival statistics in China 2019\u20132021: a multicenter, population-based study. J Natl Cancer Cent. 2024;4(3):203\u201313.","journal-title":"J Natl Cancer Cent"},{"issue":"22","key":"16104_CR3","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","volume":"378","author":"L Gandhi","year":"2018","unstructured":"Gandhi L, Rodr\u00edguez-Abreu D, Gadgeel S, Esteban E, Felip E, De Angelis F, et al. Pembrolizumab plus Chemotherapy in Metastatic Non\u2013Small-Cell Lung Cancer. N Engl J Med. 2018;378(22):2078\u201392.","journal-title":"N Engl J Med"},{"issue":"11","key":"16104_CR4","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1200\/JCO.22.01990","volume":"41","author":"S Novello","year":"2023","unstructured":"Novello S, Kowalski DM, Luft A, G\u00fcm\u00fc\u015f M, Vicente D, Mazi\u00e8res J, et al. Pembrolizumab Plus Chemotherapy in Squamous Non\u2013Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study. J Clin Oncol. 2023;41(11):1999\u20132006.","journal-title":"J Clin Oncol"},{"key":"16104_CR5","doi-asserted-by":"publisher","unstructured":"Chen LN, Wei AZ, Shu CA. Neoadjuvant immunotherapy in resectable non-small-cell lung cancer. Therapeutic Adv Med Oncol. 2023;15:17588359231163798. https:\/\/doi.org\/10.1177\/17588359231163798.","DOI":"10.1177\/17588359231163798"},{"issue":"11","key":"16104_CR6","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.jtho.2021.06.019","volume":"16","author":"J Jassem","year":"2021","unstructured":"Jassem J, de Marinis F, Giaccone G, Vergnenegre A, Barrios CH, Morise M, et al. Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1\u2013Selected NSCLC. J Thorac Oncol. 2021;16(11):1872\u201382.","journal-title":"J Thorac Oncol"},{"issue":"3","key":"16104_CR7","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jtho.2024.10.024","volume":"20","author":"S Lu","year":"2025","unstructured":"Lu S, Wu L, Wang Q, Wang Z, Lv D, Ma R, et al. Durvalumab Versus Chemotherapy as First-line Treatment for Metastatic NSCLC With Tumor PD-L1 Expression of 25% or Higher: Results From the Randomized Phase 3 PEARL Study. J Thorac Oncol. 2025;20(3):366\u201382.","journal-title":"J Thorac Oncol"},{"key":"16104_CR8","doi-asserted-by":"publisher","unstructured":"Sibille A, Corhay J-L, Louis R, Ninane V, Jerusalem G, Duysinx B. Eosinophils and Lung Cancer: From Bench to Bedside. Int J Mol Sci. 2022;23(9):5066. https:\/\/doi.org\/10.3390\/ijms23095066.","DOI":"10.3390\/ijms23095066"},{"key":"16104_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.lungcan.2020.08.015","volume":"150","author":"X Chu","year":"2020","unstructured":"Chu X, Zhao J, Zhou J, Zhou F, Jiang T, Jiang S, et al. Association of baseline peripheral-blood eosinophil count with immune checkpoint inhibitor-related pneumonitis and clinical outcomes in patients with non-small cell lung cancer receiving immune checkpoint inhibitors. Lung Cancer. 2020;150:76\u201382.","journal-title":"Lung Cancer"},{"key":"16104_CR10","first-page":"100603","volume":"32","author":"E Caliman","year":"2022","unstructured":"Caliman E, Fancelli S, Ottanelli C, Mazzoni F, Paglialunga L, Lavacchi D, et al. Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy. Cancer Treat Res Commun. 2022;32:100603.","journal-title":"Cancer Treat Res Commun"},{"issue":"30","key":"16104_CR11","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1111\/1759-7714.15100","volume":"14","author":"E Takeuchi","year":"2023","unstructured":"Takeuchi E, Kondo K, Okano Y, Ichihara S, Kunishige M, Kadota N, et al. Pretreatment eosinophil counts as a predictive biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors. Thorac Cancer. 2023;14(30):3042\u201350.","journal-title":"Thorac Cancer"},{"issue":"10","key":"16104_CR12","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41568-020-0283-9","volume":"20","author":"S Grisaru-Tal","year":"2020","unstructured":"Grisaru-Tal S, Itan M, Klion AD, Munitz A. A new dawn for eosinophils in the tumour microenvironment. Nat Rev Cancer. 2020;20(10):594\u2013607.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"16104_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1056\/NEJMra2032506","volume":"386","author":"GG Brusselle","year":"2022","unstructured":"Brusselle GG, Taichman DB, Koppelman GH. Biologic Therapies for Severe Asthma. N Engl J Med. 2022;386(2):157\u201371.","journal-title":"N Engl J Med"},{"issue":"24","key":"16104_CR14","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1056\/NEJMoa2401304","volume":"390","author":"SP Bhatt","year":"2024","unstructured":"Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Bafadhel M, Christenson SA, et al. Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation. N Engl J Med. 2024;390(24):2274\u201383.","journal-title":"N Engl J Med"},{"key":"16104_CR15","doi-asserted-by":"publisher","unstructured":"Varricchi G, Galdiero MR, Loffredo S, Lucarini V, Marone G, Mattei F, et al. Eosinophils: The unsung heroes in cancer? OncoImmunology. 2017;7(2):e1393134. https:\/\/doi.org\/10.1080\/2162402X.2017.1393134.","DOI":"10.1080\/2162402X.2017.1393134"},{"key":"16104_CR16","doi-asserted-by":"publisher","unstructured":"Kienzl M, Hasenoehrl C, Valadez-Cosmes P, Maitz K, Sarsembayeva A, Sturm E, et al. IL-33 reduces tumor growth in models of colorectal cancer with the help of eosinophils. OncoImmunology. 2020;9(1):1776059. https:\/\/doi.org\/10.1080\/2162402X.2020.1776059.","DOI":"10.1080\/2162402X.2020.1776059"},{"key":"16104_CR17","doi-asserted-by":"publisher","unstructured":"Andreone S, Spadaro F, Buccione C, Mancini J, Tinari A, Sestili P, et al. IL-33 Promotes CD11b\/CD18-Mediated Adhesion of Eosinophils to Cancer Cells and Synapse-Polarized Degranulation Leading to Tumor Cell Killing. Cancers. 2019;11(11):1664. https:\/\/doi.org\/10.3390\/cancers11111664.","DOI":"10.3390\/cancers11111664"},{"issue":"2","key":"16104_CR18","doi-asserted-by":"publisher","first-page":"703","DOI":"10.4049\/jimmunol.1101270","volume":"188","author":"M Ikutani","year":"2012","unstructured":"Ikutani M, Yanagibashi T, Ogasawara M, Tsuneyama K, Yamamoto S, Hattori Y, et al. Identification of Innate IL-5\u2013Producing Cells and Their Role in Lung Eosinophil Regulation and Antitumor Immunity. J Immunol. 2012;188(2):703\u201313.","journal-title":"J Immunol"},{"key":"16104_CR19","doi-asserted-by":"publisher","unstructured":"Ghaffari S, Rezaei N. Eosinophils in the tumor microenvironment: implications for cancer immunotherapy. J Translational Med. 2023;21(1):551. https:\/\/doi.org\/10.1186\/s12967-023-04418-7.","DOI":"10.1186\/s12967-023-04418-7"},{"issue":"6","key":"16104_CR20","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/ni.3159","volume":"16","author":"R Carretero","year":"2015","unstructured":"Carretero R, Sektioglu IM, Garbi N, Salgado OC, Beckhove P, H\u00e4mmerling GJ. Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8\u2009+\u2009T cells. Nat Immunol. 2015;16(6):609\u201317.","journal-title":"Nat Immunol"},{"issue":"6","key":"16104_CR21","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/gtc.12371","volume":"21","author":"Y Xing","year":"2016","unstructured":"Xing Y, Tian Y, Kurosawa T, Matsui S, Touma M, Yanai T, et al. CCL11-induced eosinophils inhibit the formation of blood vessels and cause tumor necrosis. Genes Cells. 2016;21(6):624\u201338.","journal-title":"Genes Cells"},{"issue":"8","key":"16104_CR22","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1158\/0008-5472.CAN-14-2379","volume":"75","author":"R Zaynagetdinov","year":"2015","unstructured":"Zaynagetdinov R, Sherrill TP, Gleaves LA, McLoed AG, Saxon JA, Habermann AC, et al. Interleukin-5 Facilitates Lung Metastasis by Modulating the Immune Microenvironment. Cancer Res. 2015;75(8):1624\u201334.","journal-title":"Cancer Res"},{"key":"16104_CR23","doi-asserted-by":"publisher","unstructured":"Li F, Du X, Lan F, Li N, Zhang C, Zhu C, et al. Eosinophilic inflammation promotes CCL6-dependent metastatic tumor growth. Sci Adv. 2021;7(22):eabb5943. https:\/\/doi.org\/10.1126\/sciadv.abb5943.","DOI":"10.1126\/sciadv.abb5943"},{"issue":"3","key":"16104_CR24","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.4049\/jimmunol.1001965","volume":"187","author":"CS Curran","year":"2011","unstructured":"Curran CS, Evans MD, Bertics PJ. GM-CSF Production by Glioblastoma Cells Has a Functional Role in Eosinophil Survival, Activation, and Growth Factor Production for Enhanced Tumor Cell Proliferation. J Immunol. 2011;187(3):1254\u201363.","journal-title":"J Immunol"},{"issue":"2","key":"16104_CR25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.canlet.2015.04.029","volume":"364","author":"F Xie","year":"2015","unstructured":"Xie F, Liu L-B, Shang W-Q, Chang K-K, Meng Y-H, Mei J, et al. The infiltration and functional regulation of eosinophils induced by TSLP promote the proliferation of cervical cancer cell. Cancer Lett. 2015;364(2):106\u201317.","journal-title":"Cancer Lett"},{"key":"16104_CR26","doi-asserted-by":"publisher","unstructured":"Zhang B, Wei CY, Chang KK, Yu JJ, Zhou WJ, Yang HL, et al. TSLP promotes angiogenesis of human umbilical vein endothelial cells by strengthening the crosstalk between cervical cancer cells and eosinophils. Oncol Lett. 2017;14(6):7483\u20138. https:\/\/doi.org\/10.3892\/ol.2017.7121.","DOI":"10.3892\/ol.2017.7121"},{"issue":"7993","key":"16104_CR27","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41586-023-06797-9","volume":"625","author":"NM LaMarche","year":"2023","unstructured":"LaMarche NM, Hegde S, Park MD, Maier BB, Troncoso L, Le Berichel J, et al. An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis. Nature. 2023;625(7993):166\u201374.","journal-title":"Nature"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16104-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16104-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16104-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:46:21Z","timestamp":1781649981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16104-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16104"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16104-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Xi\u2019an Jiaotong University (Approval No. 2025YS023). As a retrospective analysis utilizing only anonymized medical records without any intervention, the requirement for individual patient informed consent was waived by the ethics committee. The study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This manuscript does not contain any individual person \u2018s data in any form (including individual details, images or videos).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"738"}}